ULTRAGENYX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 29 Jun 2023)
What this means for you
Registered since 17 Jan 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 85898417
- Registration number
- 5124554
- Mark type
- Stylized text
- Filed
- 08 Apr 2013
- Published for opposition
- 08 Oct 2013
- Registered
- 17 Jan 2017
- Attorney of record
- Brian Focarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of genetic, neuro-muscular, osteopathic, neurologic, oncologic, metabolic, orthopedic, endocrine, and lipid-related conditions, diseases and disorders
Owner
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
Prosecution history
- 17 Jan 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 02 Aug 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Aug 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Aug 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Aug 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Aug 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Jun 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 29 Jun 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Jun 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jan 2023 — TEAS SECTION 8 & 15 RECEIVED
- 17 Jan 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Jan 2017 — REGISTERED-PRINCIPAL REGISTER
- 16 Dec 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Dec 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Dec 2016 — STATEMENT OF USE PROCESSING COMPLETE